The seventh China International Import Expo is underway, where Pfizer's China President, Jean-Christophe Pointeau, shared the company's strategy in China. Pfizer is highly focused on China's recent policies for high-quality development, especially in the realm of healthcare innovation and increased foreign investment to foster openness.
Pointeau expressed that these policies are inspiring and motivate the company to expand its investment in China over the next five years. Pfizer aims to collaborate with China's innovation sectors to develop new products, benefiting global health.
